Hologic HOLX has been gaining from new strategic product launches across Diagnostics and Breast Health. However, ...

Argus downgraded Hologic (HOLX) to Hold from Buy. The firm is citing a higher risk to the management’s FY25 outlook as the company has reduced its revenue guidance due to slower sales of ...

https://www.tipranks.com/news/the-fly/ainos-ugo-to-develop-robot-with-sense-of-smell Argus downgraded Hologic (HOLX) to Hold from Buy. The firm is citing a higher ...

Marlborough, Massachusetts-based Hologic, Inc. (HOLX) develops, manufactures, and supplies diagnostics products, imaging systems, and surgical products for women's health through early detection ...

Zacks Research cut their Q4 2025 EPS estimates for Hologic in a research note issued to investors on Wednesday, March 19th.

Under CEO Stephen MacMillans' watch, Hologic has been able to focus on structural competitive advantages, improve its balance sheet, and judiciously step into complimentary markets, which evens ...

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through ...

Decatur Morgan Hospital is expanding its breast health services, offering women access to advanced mammograms and breast biopsies that can both be performed in the same visit with a state-of-the-art ...

Hologic, Inc. (NASDAQ:HOLX), a leading medical technology company specializing in women's health, diagnostics, and medical imaging systems, has been navigating a complex market landscape ...